PROMUS Element Stent

Tags:
Boston, Scientific, Promus, Element, Everolimus-Eluting, Coronary, Stent, System, Platinum, Chromium

Add video views to your Facebook Timeline:

Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark for its PROMUS® Element™ Everolimus-Eluting Coronary Stent System, the Company’s third-generation drug-eluting stent (DES) technology. The PROMUS Element system incorporates a unique platinum chromium alloy with an innovative stent design and an advanced catheter delivery system.

To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bostonscientific/36501/

  1. By: MultiVu
  2. Categories Science & Tech
  3. Views 587
  4. Added :02-Nov-09
Comments on PROMUS Element Stent
Other comments on this video 0 Comments
 

Up Next: Binary Domain -- Exclusive Multiplayer Trailer